Organogenesis ORGO

1.41 (0.01) (0.70%) as of 25 Sep
Market cap
$207.1M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
94.33 136.15 104.34 103.29 114.53 84.81 60.37 21.41 2.36 1.04
Receivables
217.45 109.86 82.00 89.45 82.46 56.80 39.36 34.08 28.12 —
Inventory
29.63 26.22 28.25 24.78 25.02 27.80 22.92 13.32 14.27 —
Other current assets
2.43 — — 5.09 4.97 4.94 2.95 2.33 0.59 0.40
Total current assets
362.19 285.94 225.04 222.61 226.98 174.34 125.60 71.13 49.74 1.44
Property, Plant, Equpment (Net)
103.71 89.13 116.23 102.46 79.16 55.79 47.18 39.62 42.11 —
Goodwill and Intangible Assets (Total)
37.92 41.24 44.64 49.56 54.45 59.39 46.34 51.63 55.30 0.00
Long Term Assets (Tax, Deferred)
29.96 39.46 28.00 30.01 31.99 0.02 0.13 0.24 0.42 —
Long-term assets (Other)
9.20 5.01 5.99 1.52 1.54 0.67 1.44 1.06 1.15 —
Total non-current assets
236.54 211.95 234.98 226.75 216.28 115.87 95.09 92.55 98.98 —
Total Assets
598.73 497.89 460.03 449.36 443.26 290.22 220.69 163.68 148.72 0.00
Notes Payable
— — — — 2.66 16.67 — 2.55 — —
Accounts Payable
31.95 28.91 30.72 32.33 29.34 23.38 28.39 19.17 19.05 —
Accrued Expenses
49.53 39.45 30.07 26.45 37.29 23.97 23.45 20.39 22.55 —
Current Part of Debt
— — 5.49 4.54 2.66 20.29 3.06 16.81 — —
Current Part of Capital Lease
9.44 1.17 1.08 — 0.20 3.62 3.06 2.24 5.37 0.00
Current Part of Taxes to Pay
— — — — — — — — — 0.00
Other current liabilities
— — — 26.45 1.44 0.58 5.00 11.76 5.00 0.48
Total current liabilities
100.12 77.48 80.51 75.02 82.71 68.22 59.89 56.10 51.97 0.48
Long Term Debt (Total)
12.79 0.72 62.63 66.23 70.77 64.49 97.55 54.48 101.47 —
Non-current Revenue (Deferred)
— — — — — 2.32 1.01 0.13 0.07 0.00
Minority Interests
— — — — — — — — — 0.00
Non-current Liabilities (Other)
134.98 123.31 1.21 1.12 1.56 13.39 6.65 5.93 10.53 10.85
Total non-current liabilities
198.48 157.51 100.85 108.67 119.22 80.19 105.21 60.54 112.07 —
Total liabilities
298.60 234.99 181.36 183.69 201.92 148.41 165.10 116.64 157.28 0.00
Additional Paid In Capital
303.19 302.99 319.62 310.96 302.16 296.83 226.58 177.27 50.09 0.00
Preferred Stock (Total)
— — — — — — — — — 0.00
Common Stock (Net)
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00
Retained Earnings
(3.08) (40.11) (40.97) (45.30) (60.83) (155.03) (171.01) (130.24) (65.41) (0.23)
Treasury Stock
— — — — — — — — — 0.00
Shareholders Equity (Other)
— — — — — — — — — 0.00
Common Equity (Total)
300.13 262.90 278.66 265.67 241.34 141.81 55.58 47.04 (15.32) 5.00
Shareholders Equity (Total)
300.13 262.90 278.66 265.67 241.34 141.81 55.58 47.04 (8.55) 0.00
Shareholders Equity and Liabilities (Total)
598.73 497.89 460.03 449.36 443.26 290.22 220.69 163.68 148.72 0.00
Shares (Common)
126.95 125.73 131.32 130.92 128.68 127.73 104.87 91.26 66.98 —
Shareholders Equity (Tangible)
262.21 221.66 234.02 216.11 186.89 82.41 9.25 (4.59) (63.85) —
Net Debt
(81.54) (135.43) (36.22) (32.52) (41.10) (0.03) 40.24 49.88 99.11 (1.04)
Total Debt
12.79 0.72 68.12 70.77 73.43 84.77 100.61 71.29 101.47 —

Fold the line items

In millions of $ except per-share values · columns are period end dates